Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
Enhances Aclaris’ pipeline with complementary biologics portfolio -- Expands leadership team with addition of seasoned ...
NOTICE TO SECURITYHOLDERS - NOVA CHEMICALS CORPORATION ANNOUNCES PROPOSED OFFERING OF $400 MILLION OF NEW SENIOR NOTES
NOVA Chemicals Corporation ("NOVA Chemicals") announced today that it intends to offer (the "Offering") $400 million in aggregate principal amount of senior unsecured notes due 2031 (the "Notes") in a ...